METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS

METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS was reported 58857 times

METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 40 0.4167
1 PULMONARY VASCULITIS 116 0.2156
2 NEUROLOGIC NEGLECT SYNDROME 114 0.2050
3 PROLONGED EXPIRATION 40 0.1527
4 CAPILLARITIS 41 0.1486
5 HYPOCHOLESTEROLAEMIA 52 0.1473
6 TOTAL LUNG CAPACITY ABNORMAL 57 0.1465
7 HUMAN RHINOVIRUS TEST POSITIVE 54 0.1448
8 CAROTID ARTERY THROMBOSIS 120 0.1413
9 LACTIC ACIDOSIS 4559 0.1406
10 ALVEOLAR OSTEITIS 54 0.1277
11 URINARY TRACT DISCOMFORT 56 0.1215
12 CEREBRAL HYPOPERFUSION 55 0.1180
13 SPIROMETRY ABNORMAL 67 0.1120
14 VIRAL TEST POSITIVE 39 0.1074
15 EUGLYCAEMIC DIABETIC KETOACIDOSIS 418 0.1011
16 ADJUSTMENT DISORDER 117 0.0900
17 PNEUMONIA HAEMOPHILUS 43 0.0885
18 MITE ALLERGY 56 0.0855
19 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 55 0.0782
20 DIABETIC METABOLIC DECOMPENSATION 102 0.0734
21 HYPOGLYCAEMIC COMA 204 0.0707
22 MYCOTIC ALLERGY 58 0.0678
23 NEURITIS 102 0.0660
24 HYPERLACTACIDAEMIA 175 0.0652
25 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 47 0.0641
26 FACET JOINT SYNDROME 208 0.0638
27 CONTINUOUS HAEMODIAFILTRATION 61 0.0623
28 ANIMAL SCRATCH 57 0.0586
29 DUST ALLERGY 57 0.0581
30 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 53 0.0572
31 KETOSIS 54 0.0498
32 PERIPHERAL VENOUS DISEASE 201 0.0492
33 PERSONALITY DISORDER 128 0.0488
34 CONJUNCTIVITIS ALLERGIC 71 0.0479
35 METABOLIC ACIDOSIS 1438 0.0449
36 ONYCHOMADESIS 186 0.0443
37 ONYCHOMYCOSIS 189 0.0430
38 DISTRIBUTIVE SHOCK 95 0.0419
39 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 85 0.0416
40 VITAMIN B12 DEFICIENCY 161 0.0397
41 RESPIRATORY SYMPTOM 113 0.0397
42 INFUSION SITE DISCHARGE 64 0.0365
43 HYPOGLYCAEMIA 1645 0.0339
44 BLEPHAROSPASM 208 0.0330
45 RHEUMATIC FEVER 139 0.0312
46 BREAST CANCER STAGE III 196 0.0302
47 LUPUS VULGARIS 38 0.0302
48 DIABETES MELLITUS INADEQUATE CONTROL 534 0.0301
49 C-REACTIVE PROTEIN ABNORMAL 193 0.0301
50 EXPOSURE VIA INGESTION 75 0.0297
51 VASOPLEGIA SYNDROME 47 0.0286
52 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 204 0.0284
53 TUNNEL VISION 53 0.0283
54 URINE KETONE BODY PRESENT 43 0.0272
55 HAEMODIALYSIS 224 0.0266
56 DUODENAL ULCER PERFORATION 198 0.0266
57 SINUS PAIN 62 0.0266
58 DISLOCATION OF VERTEBRA 60 0.0263
59 BLOOD LACTIC ACID INCREASED 138 0.0262
60 FINGER DEFORMITY 126 0.0260
61 KETOACIDOSIS 193 0.0258
62 HYPOGLYCAEMIA NEONATAL 40 0.0247
63 FOLLICULITIS 259 0.0247
64 NORMOCHROMIC NORMOCYTIC ANAEMIA 73 0.0243
65 DIABETIC NEPHROPATHY 53 0.0241
66 MUSCLE INJURY 197 0.0238
67 HYPERKALAEMIA 832 0.0237
68 FORCED EXPIRATORY VOLUME DECREASED 67 0.0236
69 RALES 137 0.0236
70 BURSITIS 283 0.0233
71 POLYMYALGIA RHEUMATICA 73 0.0230
72 EYELID PAIN 46 0.0226
73 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 52 0.0225
74 INFUSION SITE HAEMORRHAGE 74 0.0225
75 TONGUE BITING 46 0.0223
76 EAR CONGESTION 60 0.0221
77 ANURIA 190 0.0221
78 DEEP VEIN THROMBOSIS POSTOPERATIVE 44 0.0220
79 SHOCK 505 0.0219
80 NEUROLOGICAL SYMPTOM 125 0.0218
81 ACUTE KIDNEY INJURY 3303 0.0216
82 DIABETIC KETOACIDOSIS 517 0.0215
83 PULMONARY ALVEOLAR HAEMORRHAGE 120 0.0214
84 NAIL DISORDER 185 0.0211
85 HYPOTHERMIA 213 0.0210
86 ALANINE AMINOTRANSFERASE ABNORMAL 44 0.0208
87 DIABETIC NEUROPATHY 101 0.0204
88 VITAMIN B12 DECREASED 58 0.0201
89 HYPERCHOLESTEROLAEMIA 194 0.0201
90 OSTEOLYSIS 41 0.0200
91 LIVE BIRTH 166 0.0198
92 INFUSION SITE INFECTION 46 0.0198
93 ARTERIOSCLEROSIS CORONARY ARTERY 131 0.0198
94 INFUSION SITE REACTION 59 0.0197
95 LIP DRY 178 0.0196
96 BACK INJURY 213 0.0196
97 HEMIPLEGIA 162 0.0195
98 PEMPHIGUS 242 0.0193
99 GLYCOSYLATED HAEMOGLOBIN INCREASED 486 0.0192
100 SYNOVITIS 347 0.0192
101 JOINT RANGE OF MOTION DECREASED 258 0.0192
102 WOUND COMPLICATION 66 0.0192
103 HYPOVOLAEMIA 112 0.0191
104 DIABETIC RETINOPATHY 65 0.0191
105 HELICOBACTER INFECTION 196 0.0191
106 HAND DEFORMITY 250 0.0190
107 INFUSION SITE BRUISING 41 0.0190
108 OBSTRUCTIVE AIRWAYS DISORDER 211 0.0189
109 OBESITY 299 0.0187
110 BLADDER PAIN 58 0.0183
111 PARANASAL SINUS DISCOMFORT 69 0.0182
112 ACIDOSIS 138 0.0180
113 HYPERGLYCAEMIA 646 0.0177
114 POTENTIATING DRUG INTERACTION 58 0.0173
115 WOUND INFECTION 188 0.0172
116 DRUG LEVEL INCREASED 284 0.0171
117 TYPE 2 DIABETES MELLITUS 576 0.0171
118 PRODUCT ODOUR ABNORMAL 178 0.0170
119 MEDICATION RESIDUE PRESENT 81 0.0170
120 DRUG LEVEL ABOVE THERAPEUTIC 77 0.0168
121 TOXIC ENCEPHALOPATHY 85 0.0168
122 BONE EROSION 59 0.0167
123 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 283 0.0166
124 SENSORY LOSS 134 0.0166
125 FULL BLOOD COUNT ABNORMAL 176 0.0166
126 HYPOMAGNESAEMIA 229 0.0164
127 BLOOD GLUCOSE FLUCTUATION 179 0.0163
128 PEMPHIGOID 123 0.0163
129 CONGENITAL ANOMALY 126 0.0163
130 GANGRENE 97 0.0161
131 PRODUCT ADMINISTRATION INTERRUPTED 126 0.0160
132 PULSELESS ELECTRICAL ACTIVITY 67 0.0160
133 NORMAL NEWBORN 87 0.0160
134 GRIP STRENGTH DECREASED 139 0.0158
135 KERATITIS 48 0.0158
136 PERICARDITIS 265 0.0158
137 TASTE DISORDER 317 0.0156
138 SEASONAL ALLERGY 221 0.0156
139 AFFECT LABILITY 150 0.0156
140 EXPOSURE DURING PREGNANCY 955 0.0153
141 PANCREATIC CARCINOMA METASTATIC 43 0.0151
142 WOUND SECRETION 59 0.0151
143 PRODUCT RESIDUE PRESENT 80 0.0148
144 WRONG PATIENT RECEIVED PRODUCT 43 0.0147
145 HYPOVOLAEMIC SHOCK 70 0.0146
146 PRODUCT LABEL CONFUSION 85 0.0146
147 INFUSION SITE PRURITUS 46 0.0146
148 COMA SCALE ABNORMAL 42 0.0145
149 SKIN INJURY 48 0.0145
150 BLOOD SODIUM INCREASED 39 0.0144
151 HEPATIC FIBROSIS 49 0.0143
152 BRONCHIECTASIS 96 0.0142
153 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37 0.0141
154 INFUSION SITE PAIN 178 0.0138
155 HAEMOGLOBIN INCREASED 63 0.0138
156 HAEMODYNAMIC INSTABILITY 104 0.0136
157 BLOOD PHOSPHORUS INCREASED 37 0.0135
158 NASAL POLYPS 66 0.0134
159 BLOOD PRESSURE SYSTOLIC INCREASED 260 0.0133
160 DEPRESSIVE SYMPTOM 47 0.0133
161 MOTOR DYSFUNCTION 135 0.0132
162 CUTANEOUS VASCULITIS 48 0.0131
163 PANCREATITIS ACUTE 292 0.0130
164 C-REACTIVE PROTEIN INCREASED 468 0.0128
165 INFUSION SITE ERYTHEMA 108 0.0128
166 WOUND 354 0.0127
167 HEPATIC STEATOSIS 233 0.0125
168 MOUTH HAEMORRHAGE 91 0.0124
169 INFUSION SITE SWELLING 78 0.0124
170 CONTRAINDICATED PRODUCT ADMINISTERED 373 0.0123
171 HEPATIC CYTOLYSIS 155 0.0121
172 IRRITABLE BOWEL SYNDROME 259 0.0121
173 BLOOD GLUCOSE ABNORMAL 222 0.0120
174 MULTIPLE ORGAN DYSFUNCTION SYNDROME 338 0.0119
175 SINUS DISORDER 236 0.0119
176 ARTERIOSCLEROSIS 111 0.0118
177 BLOOD PRESSURE DIASTOLIC DECREASED 87 0.0118
178 BLOOD IRON DECREASED 139 0.0117
179 VASCULITIS 136 0.0117
180 GLOSSODYNIA 261 0.0116
181 APPETITE DISORDER 77 0.0116
182 SKIN HAEMORRHAGE 172 0.0116
183 RED CELL DISTRIBUTION WIDTH INCREASED 48 0.0115
184 COELIAC DISEASE 112 0.0114
185 RENAL FAILURE ACUTE 484 0.0114
186 DIABETES MELLITUS 869 0.0114
187 HEMIPARESIS 193 0.0114
188 OPTIC ISCHAEMIC NEUROPATHY 44 0.0114
189 FIBROMYALGIA 276 0.0113
190 POLYURIA 92 0.0112
191 RENAL TUBULAR NECROSIS 110 0.0112
192 PULMONARY FIBROSIS 214 0.0111
193 HYPERVOLAEMIA 55 0.0111
194 RESPIRATION ABNORMAL 76 0.0110
195 CARDIAC DYSFUNCTION 41 0.0110
196 AZOTAEMIA 44 0.0110
197 MUSCLE SPASTICITY 135 0.0110
198 LIVER INJURY 268 0.0109
199 ARTERIAL OCCLUSIVE DISEASE 85 0.0108
200 OLIGURIA 67 0.0108
201 DRUG-INDUCED LIVER INJURY 338 0.0108
202 MULTIPLE ALLERGIES 84 0.0107
203 MYOPATHY 92 0.0106
204 OSTEOARTHRITIS 451 0.0106
205 DYSLIPIDAEMIA 54 0.0106
206 INFLAMMATORY MARKER INCREASED 52 0.0105
207 HYPERNATRAEMIA 52 0.0104
208 ELECTROLYTE IMBALANCE 119 0.0102
209 RENAL CYST 81 0.0102
210 TUBULOINTERSTITIAL NEPHRITIS 191 0.0102
211 LUNG DISORDER 499 0.0102
212 BLINDNESS TRANSIENT 75 0.0102
213 PSORIATIC ARTHROPATHY 411 0.0101
214 COORDINATION ABNORMAL 140 0.0100
215 ADVERSE REACTION 133 0.0100
216 GLUCOSE TOLERANCE IMPAIRED 59 0.0100
217 BLOOD CHOLESTEROL INCREASED 463 0.0099
218 LOWER RESPIRATORY TRACT INFECTION 450 0.0099
219 WHEEZING 579 0.0098
220 RESPIRATORY TRACT CONGESTION 153 0.0096
221 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
222 BODY TEMPERATURE DECREASED 94 0.0095
223 COMPLETED SUICIDE 793 0.0095
224 OVERWEIGHT 51 0.0095
225 INTENTIONAL OVERDOSE 607 0.0095
226 SOPOR 125 0.0094
227 EXOSTOSIS 86 0.0094
228 TACHYPNOEA 128 0.0094
229 GAIT INABILITY 314 0.0094
230 TROPONIN INCREASED 71 0.0093
231 DYSARTHRIA 351 0.0093
232 UROSEPSIS 86 0.0093
233 BENIGN PROSTATIC HYPERPLASIA 48 0.0093
234 HYPOKINESIA 134 0.0092
235 HEPATIC CIRRHOSIS 172 0.0091
236 BLOOD GLUCOSE INCREASED 1723 0.0091
237 GLOMERULAR FILTRATION RATE DECREASED 112 0.0091
238 DYSPNOEA EXERTIONAL 343 0.0091
239 NEPHROGENIC ANAEMIA 42 0.0091
240 HYPERURICAEMIA 37 0.0090
241 LIVER FUNCTION TEST INCREASED 193 0.0090
242 PRODUCTIVE COUGH 429 0.0090
243 NIGHT SWEATS 289 0.0090
244 CORONARY ARTERY STENOSIS 45 0.0089
245 ESCHERICHIA URINARY TRACT INFECTION 38 0.0089
246 CONGESTIVE CARDIOMYOPATHY 37 0.0089
247 BLOOD CHOLESTEROL ABNORMAL 41 0.0089
248 METABOLIC DISORDER 51 0.0088
249 EPILEPSY 268 0.0088
250 ATRIOVENTRICULAR BLOCK FIRST DEGREE 38 0.0088
251 FLANK PAIN 82 0.0087
252 TOXICITY TO VARIOUS AGENTS 1474 0.0087
253 SKIN LACERATION 95 0.0087
254 PRODUCT SOLUBILITY ABNORMAL 44 0.0087
255 ACUTE CORONARY SYNDROME 72 0.0087
256 IRON DEFICIENCY 39 0.0087
257 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 416 0.0087
258 PYELONEPHRITIS 75 0.0086
259 HEPATITIS 221 0.0086
260 BLOOD MAGNESIUM DECREASED 74 0.0086
261 MITRAL VALVE INCOMPETENCE 97 0.0086
262 EATING DISORDER 182 0.0085
263 BREATH SOUNDS ABNORMAL 42 0.0085
264 HYPOTHYROIDISM 272 0.0085
265 IMPAIRED HEALING 279 0.0085
266 RED BLOOD CELL SEDIMENTATION RATE INCREASED 94 0.0085
267 NOCTURIA 103 0.0085
268 FOREIGN BODY SENSATION IN EYES 54 0.0085
269 BLOOD GLUCOSE DECREASED 405 0.0084
270 HYPOCALCAEMIA 159 0.0084
271 ATRIOVENTRICULAR BLOCK COMPLETE 56 0.0084
272 LEFT VENTRICULAR DYSFUNCTION 56 0.0084
273 MYOSITIS 75 0.0084
274 CHOKING SENSATION 46 0.0083
275 LIMB INJURY 226 0.0083
276 UPPER RESPIRATORY TRACT INFECTION 384 0.0083
277 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 42 0.0083
278 SCIATICA 132 0.0083
279 ANAL INCONTINENCE 74 0.0082
280 CARDIOGENIC SHOCK 118 0.0082
281 GASTROENTERITIS 119 0.0081
282 HAEMOLYTIC ANAEMIA 72 0.0080
283 PARKINSONISM 78 0.0080
284 GASTROOESOPHAGEAL REFLUX DISEASE 643 0.0080
285 BLISTER 448 0.0080
286 SINUS CONGESTION 107 0.0079
287 ANGINA PECTORIS 226 0.0079
288 RESPIRATORY RATE INCREASED 70 0.0079
289 APHASIA 238 0.0079
290 SLEEP APNOEA SYNDROME 150 0.0079
291 EYE PAIN 441 0.0078
292 BRADYKINESIA 46 0.0078
293 SINUS TACHYCARDIA 110 0.0077
294 HYPERTRIGLYCERIDAEMIA 45 0.0077
295 INSURANCE ISSUE 117 0.0076
296 CHOLECYSTITIS 91 0.0076
297 IMPAIRED GASTRIC EMPTYING 104 0.0076
298 BLOOD POTASSIUM INCREASED 123 0.0076
299 PRODUCT DOSE OMISSION IN ERROR 214 0.0075
300 MICTURITION URGENCY 86 0.0075
301 PRE-EXISTING CONDITION IMPROVED 47 0.0075
302 ALTERED STATE OF CONSCIOUSNESS 163 0.0075
303 SYSTEMIC LUPUS ERYTHEMATOSUS 266 0.0075
304 BLOOD PRESSURE INADEQUATELY CONTROLLED 45 0.0075
305 HYPOKALAEMIA 345 0.0075
306 GASTROINTESTINAL DISORDER 668 0.0074
307 COVID-19 PNEUMONIA 88 0.0074
308 BLOOD URIC ACID INCREASED 43 0.0074
309 JOINT INJURY 159 0.0074
310 HYPOPHAGIA 190 0.0074
311 NEPHROPATHY 69 0.0074
312 PERIPHERAL VASCULAR DISORDER 38 0.0074
313 ENCEPHALOPATHY 181 0.0074
314 DERMATITIS CONTACT 84 0.0074
315 ACUTE MYOCARDIAL INFARCTION 216 0.0073
316 LIPASE INCREASED 56 0.0073
317 FRUSTRATION TOLERANCE DECREASED 59 0.0073
318 HYPOTENSION 1462 0.0073
319 CONFUSIONAL STATE 1173 0.0073
320 RENAL FAILURE 961 0.0072
321 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 74 0.0072
322 MYOCARDITIS 82 0.0071
323 EAR PAIN 139 0.0071
324 BLOOD CREATININE INCREASED 466 0.0071
325 SHOCK HAEMORRHAGIC 58 0.0071
326 RENAL IMPAIRMENT 596 0.0071
327 INFLAMMATION 365 0.0071
328 MATERNAL EXPOSURE DURING PREGNANCY 629 0.0070
329 MUSCULAR WEAKNESS 790 0.0069
330 FAECALOMA 38 0.0069
331 LARGE INTESTINE POLYP 48 0.0069
332 ARTHROPATHY 385 0.0069
333 CATARACT OPERATION 41 0.0069
334 HYPOPHOSPHATAEMIA 51 0.0069
335 BLOOD URINE PRESENT 131 0.0069
336 CAESAREAN SECTION 80 0.0069
337 MYOCARDIAL ISCHAEMIA 78 0.0068
338 SPUTUM DISCOLOURED 65 0.0068
339 DRUG INTERACTION 1086 0.0068
340 HAEMOPTYSIS 190 0.0068
341 SKIN FISSURES 133 0.0068
342 CONCOMITANT DISEASE AGGRAVATED 42 0.0068
343 DEHYDRATION 906 0.0068
344 RHABDOMYOLYSIS 283 0.0068
345 DIARRHOEA 4375 0.0068
346 HYPERVENTILATION 39 0.0067
347 HYPONATRAEMIA 379 0.0067
348 ATRIOVENTRICULAR BLOCK 52 0.0067
349 DECREASED APPETITE 1562 0.0067
350 CHOLECYSTITIS ACUTE 38 0.0067
351 DIZZINESS POSTURAL 65 0.0067
352 HYPERLIPIDAEMIA 80 0.0067
353 CHOLELITHIASIS 219 0.0067
354 THERAPEUTIC PRODUCT EFFECT DECREASED 298 0.0066
355 ABDOMINAL DISCOMFORT 1116 0.0066
356 PRODUCT TASTE ABNORMAL 90 0.0066
357 HYPERCALCAEMIA 82 0.0066
358 URINE OUTPUT DECREASED 58 0.0066
359 LEUKOCYTOSIS 120 0.0066
360 HYPERTHYROIDISM 96 0.0066
361 CYSTITIS 211 0.0066
362 HYPOXIA 233 0.0066
363 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 470 0.0066
364 PANCREATITIS 349 0.0066
365 OCULAR DISCOMFORT 74 0.0066
366 GASTROINTESTINAL INFECTION 59 0.0066
367 PRODUCT DISTRIBUTION ISSUE 61 0.0066
368 FEELING COLD 183 0.0066
369 VITAMIN D DEFICIENCY 64 0.0066
370 ISCHAEMIC STROKE 117 0.0065
371 LOW BIRTH WEIGHT BABY 52 0.0065
372 BASAL CELL CARCINOMA 102 0.0065
373 OXYGEN SATURATION DECREASED 367 0.0065
374 BRADYCARDIA 346 0.0065
375 WALKING AID USER 43 0.0065
376 CIRCULATORY COLLAPSE 111 0.0065
377 COMA 310 0.0065
378 EOSINOPHILIA 114 0.0065
379 ASTHMA 735 0.0065
380 CATARACT 387 0.0065
381 BRONCHITIS 481 0.0065
382 FOOT DEFORMITY 72 0.0065
383 MUSCULOSKELETAL PAIN 340 0.0065
384 DYSURIA 238 0.0065
385 SUICIDE ATTEMPT 392 0.0065
386 HYPOAESTHESIA ORAL 97 0.0064
387 MOBILITY DECREASED 461 0.0064
388 PREMATURE DELIVERY 102 0.0064
389 BLOOD TRIGLYCERIDES INCREASED 113 0.0064
390 HEPATITIS ACUTE 41 0.0063
391 EJECTION FRACTION DECREASED 98 0.0063
392 LOCALISED INFECTION 152 0.0063
393 DRUG INTOLERANCE 607 0.0063
394 BLOOD UREA INCREASED 105 0.0063
395 DRY MOUTH 506 0.0062
396 NEPHROLITHIASIS 286 0.0062
397 MELAENA 137 0.0062
398 CARDIAC FAILURE 499 0.0062
399 PERIPHERAL SWELLING 951 0.0062
400 CARDIOMYOPATHY 91 0.0062
401 HAEMATURIA 210 0.0061
402 NODULE 80 0.0061
403 CHOLANGITIS 38 0.0061
404 RHINORRHOEA 396 0.0061
405 CARDIAC MURMUR 53 0.0061
406 SLEEP DISORDER 431 0.0061
407 ILLNESS 629 0.0061
408 HAEMATOCRIT DECREASED 121 0.0061
409 ANKLE FRACTURE 94 0.0061
410 FAECES SOFT 44 0.0060
411 OEDEMA 328 0.0060
412 DYSPEPSIA 595 0.0060
413 PULMONARY MASS 90 0.0060
414 TRICUSPID VALVE INCOMPETENCE 48 0.0060
415 ABDOMINAL DISTENSION 630 0.0060
416 URINARY INCONTINENCE 178 0.0060
417 ANGINA UNSTABLE 39 0.0060
418 CARDIAC ARREST 493 0.0060
419 DUODENAL ULCER 42 0.0059
420 WEIGHT FLUCTUATION 62 0.0059
421 GLAUCOMA 114 0.0059
422 COUGH 1658 0.0059
423 DECUBITUS ULCER 48 0.0059
424 NECK PAIN 328 0.0059
425 TOXIC SKIN ERUPTION 59 0.0059
426 IRON DEFICIENCY ANAEMIA 54 0.0058
427 HYPERTENSIVE CRISIS 65 0.0058
428 HEPATIC ENZYME INCREASED 398 0.0058
429 GAMMA-GLUTAMYLTRANSFERASE INCREASED 129 0.0058
430 BRADYPHRENIA 38 0.0058
431 MUSCULOSKELETAL CHEST PAIN 90 0.0058
432 PRESYNCOPE 141 0.0058
433 SNEEZING 130 0.0058
434 FALL 1926 0.0058
435 SINUSITIS 591 0.0058
436 SYNCOPE 574 0.0057
437 CEREBRAL INFARCTION 140 0.0057
438 BLOOD SODIUM DECREASED 108 0.0057
439 DIALYSIS 81 0.0057
440 HYPERTENSION 1208 0.0057
441 DIVERTICULITIS 158 0.0057
442 BLOOD PRESSURE ABNORMAL 113 0.0057
443 ASTHENIA 2137 0.0057
444 VOMITING 2670 0.0057
445 INFUSION RELATED REACTION 376 0.0057
446 WRONG PRODUCT ADMINISTERED 38 0.0056
447 ACUTE RESPIRATORY FAILURE 108 0.0056
448 CELLULITIS 282 0.0056
449 VENTRICULAR FIBRILLATION 62 0.0056
450 ABNORMAL LOSS OF WEIGHT 38 0.0056
451 POLLAKIURIA 232 0.0056
452 BRAIN FOG 87 0.0055
453 ACCIDENTAL OVERDOSE 203 0.0055
454 WEIGHT DECREASED 1545 0.0055
455 FOETAL EXPOSURE DURING PREGNANCY 449 0.0055
456 BALANCE DISORDER 477 0.0055
457 INTENTIONAL PRODUCT USE ISSUE 482 0.0055
458 RED BLOOD CELL COUNT DECREASED 157 0.0055
459 CHOLESTASIS 105 0.0055
460 SPINAL OSTEOARTHRITIS 48 0.0055
461 ORTHOSTATIC HYPOTENSION 95 0.0055
462 BLOOD PRESSURE INCREASED 831 0.0054
463 SEPTIC SHOCK 236 0.0054
464 NEOPLASM 62 0.0054
465 STOMATITIS 327 0.0054
466 BRAIN INJURY 54 0.0054
467 PULMONARY CONGESTION 71 0.0054
468 EAR INFECTION 143 0.0054
469 INFLUENZA 599 0.0054
470 PNEUMONIA ASPIRATION 134 0.0054
471 MIDDLE INSOMNIA 100 0.0053
472 CORONARY ARTERY DISEASE 162 0.0053
473 NASOPHARYNGITIS 982 0.0053
474 BLOOD POTASSIUM DECREASED 160 0.0053
475 GENERAL PHYSICAL HEALTH DETERIORATION 614 0.0053
476 CARPAL TUNNEL SYNDROME 74 0.0053
477 SMALL INTESTINAL OBSTRUCTION 65 0.0053
478 FOOT FRACTURE 100 0.0053
479 UNRESPONSIVE TO STIMULI 136 0.0053
480 INITIAL INSOMNIA 54 0.0053
481 CHEST DISCOMFORT 535 0.0052
482 BLOOD PRESSURE DECREASED 347 0.0052
483 BLOOD THYROID STIMULATING HORMONE INCREASED 48 0.0052
484 GASTROENTERITIS VIRAL 94 0.0052
485 THIRST 93 0.0052
486 ASPIRATION 57 0.0052
487 SWELLING 487 0.0052
488 OROPHARYNGEAL DISCOMFORT 47 0.0052
489 BLOOD CREATINE PHOSPHOKINASE INCREASED 149 0.0052
490 SINUS BRADYCARDIA 50 0.0052
491 POISONING DELIBERATE 49 0.0052
492 URINARY TRACT INFECTION 881 0.0052
493 ACUTE RESPIRATORY DISTRESS SYNDROME 91 0.0051
494 SKIN ULCER 133 0.0051
495 JOINT SWELLING 621 0.0051
496 GOUT 92 0.0051
497 PRESCRIBED OVERDOSE 99 0.0051
498 RESPIRATORY DISORDER 153 0.0051
499 MIGRAINE 487 0.0051
500 BOWEL MOVEMENT IRREGULARITY 39 0.0051
501 COVID-19 891 0.0051
502 DELIRIUM 176 0.0051
503 ATRIAL FIBRILLATION 493 0.0051
504 HEAD INJURY 160 0.0051
505 DEPRESSED MOOD 267 0.0050
506 COLD SWEAT 89 0.0050
507 BODY TEMPERATURE INCREASED 103 0.0050
508 PULMONARY HYPERTENSION 105 0.0050
509 AUTOIMMUNE DISORDER 49 0.0050
510 CHOKING 98 0.0050
511 CARDIO-RESPIRATORY ARREST 210 0.0050
512 RETCHING 107 0.0050
513 NEURALGIA 122 0.0050
514 TOOTH INFECTION 66 0.0050
515 LYMPHOCYTE COUNT DECREASED 88 0.0050
516 ABDOMINAL PAIN 1158 0.0050
517 RESTLESS LEGS SYNDROME 90 0.0049
518 MUSCLE SPASMS 907 0.0049
519 FLATULENCE 279 0.0049
520 MEMORY IMPAIRMENT 675 0.0049
521 RHEUMATOID ARTHRITIS 557 0.0049
522 WHITE BLOOD CELL COUNT INCREASED 188 0.0049
523 MENTAL STATUS CHANGES 136 0.0049
524 MUSCULOSKELETAL STIFFNESS 429 0.0049
525 MOVEMENT DISORDER 157 0.0049
526 LIMB DISCOMFORT 151 0.0049
527 CARDIOMEGALY 60 0.0049
528 RESPIRATORY TRACT INFECTION 127 0.0049
529 FLUID RETENTION 248 0.0049
530 INTENTIONAL DOSE OMISSION 139 0.0049
531 SECRETION DISCHARGE 61 0.0049
532 BLOOD LACTATE DEHYDROGENASE INCREASED 77 0.0049
533 DRUG EFFECT LESS THAN EXPECTED 72 0.0049
534 UPPER-AIRWAY COUGH SYNDROME 40 0.0049
535 HYPERTHERMIA 37 0.0048
536 GASTRIC ULCER 92 0.0048
537 PHOTOPHOBIA 91 0.0048
538 SCRATCH 51 0.0048
539 TRANSIENT ISCHAEMIC ATTACK 163 0.0048
540 ILL-DEFINED DISORDER 292 0.0048
541 PHARYNGEAL SWELLING 47 0.0048
542 NASAL CONGESTION 282 0.0048
543 TENDERNESS 50 0.0048
544 CHRONIC KIDNEY DISEASE 364 0.0048
545 ABDOMINAL PAIN UPPER 985 0.0048
546 PREMATURE BABY 144 0.0048
547 GINGIVAL PAIN 38 0.0048
548 ARTHRITIS 375 0.0048
549 PARAESTHESIA 750 0.0048
550 SKIN EXFOLIATION 401 0.0047
551 DYSPNOEA 2682 0.0047
552 HALLUCINATION, VISUAL 100 0.0047
553 OBSESSIVE-COMPULSIVE DISORDER 38 0.0047
554 AGRANULOCYTOSIS 88 0.0047
555 HYPERSOMNIA 135 0.0047
556 INTERSTITIAL LUNG DISEASE 228 0.0047
557 POISONING 59 0.0047
558 PAIN IN EXTREMITY 1381 0.0047
559 SKIN REACTION 66 0.0047
560 OROPHARYNGEAL PAIN 433 0.0047
561 RESPIRATORY FAILURE 341 0.0047
562 HERNIA 90 0.0046
563 OSTEOPOROSIS 191 0.0046
564 BLOOD PRESSURE FLUCTUATION 111 0.0046
565 CANDIDA INFECTION 78 0.0046
566 PNEUMONIA 1495 0.0046
567 AGEUSIA 115 0.0046
568 SCHIZOPHRENIA 56 0.0046
569 PRODUCT ADMINISTRATION ERROR 93 0.0046
570 PHARYNGITIS 57 0.0046
571 WRIST FRACTURE 55 0.0046
572 LIVER DISORDER 203 0.0046
573 LETHARGY 263 0.0046
574 LOSS OF CONSCIOUSNESS 585 0.0046
575 SCAB 52 0.0046
576 ANAEMIA 869 0.0046
577 INTERNAL HAEMORRHAGE 52 0.0045
578 PRODUCT DOSE OMISSION ISSUE 1338 0.0045
579 ATRIAL SEPTAL DEFECT 38 0.0045
580 HALLUCINATION, AUDITORY 72 0.0045
581 CHEST PAIN 839 0.0045
582 PURPURA 40 0.0045
583 MUSCLE RIGIDITY 54 0.0045
584 OEDEMA PERIPHERAL 550 0.0045
585 NEUROPATHY PERIPHERAL 429 0.0045
586 NAUSEA 3568 0.0045
587 HAEMOGLOBIN DECREASED 462 0.0045
588 METASTASES TO LIVER 79 0.0045
589 SPEECH DISORDER 235 0.0045
590 LACRIMATION INCREASED 135 0.0045
591 CORONARY ARTERY OCCLUSION 61 0.0044
592 DELUSION 69 0.0044
593 CONSTIPATION 968 0.0044
594 FEEDING DISORDER 90 0.0044
595 TREATMENT NONCOMPLIANCE 242 0.0044
596 EYE HAEMORRHAGE 59 0.0044
597 HEART RATE INCREASED 437 0.0044
598 GASTRITIS 116 0.0044
599 PRODUCT PRESCRIBING ERROR 105 0.0044
600 THERAPY NON-RESPONDER 198 0.0044
601 ERECTILE DYSFUNCTION 113 0.0044
602 ERYTHEMA MULTIFORME 41 0.0044
603 OESOPHAGITIS 48 0.0044
604 HEART RATE DECREASED 154 0.0044
605 RESPIRATORY DISTRESS 121 0.0044
606 DYSSTASIA 128 0.0044
607 HYPOAESTHESIA 656 0.0044
608 HAEMATEMESIS 111 0.0044
609 HOT FLUSH 330 0.0044
610 DEPRESSED LEVEL OF CONSCIOUSNESS 173 0.0044
611 FREQUENT BOWEL MOVEMENTS 118 0.0044
612 SKIN INFECTION 49 0.0044
613 ADRENAL INSUFFICIENCY 53 0.0044
614 INJURY 307 0.0044
615 PRESCRIBED UNDERDOSE 87 0.0044
616 FLUSHING 443 0.0044
617 DECREASED ACTIVITY 47 0.0044
618 LIGAMENT SPRAIN 43 0.0043
619 FAECES DISCOLOURED 94 0.0043
620 CARDIOVASCULAR DISORDER 110 0.0043
621 WEIGHT INCREASED 968 0.0043
622 DIZZINESS 2155 0.0043
623 SARS-COV-2 TEST POSITIVE 57 0.0043
624 HUNGER 60 0.0043
625 BODY HEIGHT DECREASED 46 0.0043
626 HYPERHIDROSIS 554 0.0043
627 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38 0.0043
628 EUPHORIC MOOD 44 0.0043
629 DEPRESSION 976 0.0043
630 TOXIC EPIDERMAL NECROLYSIS 65 0.0043
631 INTERNATIONAL NORMALISED RATIO INCREASED 122 0.0043
632 MUSCLE STRAIN 37 0.0043
633 PULMONARY OEDEMA 191 0.0043
634 PRODUCT USE COMPLAINT 67 0.0042
635 SUDDEN DEATH 45 0.0042
636 CYTOKINE RELEASE SYNDROME 85 0.0042
637 BACTERIAL INFECTION 79 0.0042
638 THROAT IRRITATION 189 0.0042
639 DISCOMFORT 257 0.0042
640 MALNUTRITION 47 0.0042
641 MUSCLE ATROPHY 53 0.0042
642 BACK DISORDER 68 0.0042
643 HEPATIC FUNCTION ABNORMAL 156 0.0042
644 DIARRHOEA HAEMORRHAGIC 39 0.0042
645 ACUTE HEPATIC FAILURE 57 0.0042
646 GAIT DISTURBANCE 793 0.0041
647 FEELING HOT 254 0.0041
648 RENAL DISORDER 193 0.0041
649 VENTRICULAR EXTRASYSTOLES 43 0.0041
650 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216 0.0041
651 MEDICATION ERROR 230 0.0041
652 CONDITION AGGRAVATED 1257 0.0041
653 NEUROLEPTIC MALIGNANT SYNDROME 49 0.0041
654 DRUG ERUPTION 73 0.0041
655 VENTRICULAR TACHYCARDIA 68 0.0041
656 URINARY RETENTION 137 0.0041
657 MALAISE 1799 0.0041
658 HIATUS HERNIA 53 0.0041
659 POLYNEUROPATHY 49 0.0041
660 ANAPHYLACTIC REACTION 226 0.0041
661 THROMBOSIS 328 0.0041
662 INTERVERTEBRAL DISC PROTRUSION 89 0.0041
663 MUSCULOSKELETAL DISCOMFORT 70 0.0041
664 KNEE OPERATION 40 0.0041
665 PRURITUS 1561 0.0041
666 SPINAL OPERATION 50 0.0041
667 HAEMATOMA 105 0.0040
668 PROTEINURIA 77 0.0040
669 NERVE INJURY 45 0.0040
670 FATIGUE 3150 0.0040
671 BACK PAIN 939 0.0040
672 ALANINE AMINOTRANSFERASE INCREASED 248 0.0040
673 SEPSIS 450 0.0040
674 MYALGIA 685 0.0040
675 KIDNEY INFECTION 79 0.0040
676 IMPAIRED WORK ABILITY 86 0.0040
677 DIPLOPIA 104 0.0040
678 RASH MACULO-PAPULAR 89 0.0040
679 ASPARTATE AMINOTRANSFERASE INCREASED 212 0.0040
680 ARTHRALGIA 1658 0.0040
681 VERTIGO 243 0.0040
682 TACHYCARDIA 354 0.0040
683 METASTASES TO LUNG 46 0.0040
684 GENERALISED OEDEMA 49 0.0040
685 TRANSAMINASES INCREASED 88 0.0040
686 ORAL CANDIDIASIS 52 0.0039
687 ADVERSE DRUG REACTION 354 0.0039
688 RIB FRACTURE 81 0.0039
689 CONTUSION 379 0.0039
690 MULTI-ORGAN FAILURE 68 0.0039
691 TOOTH ABSCESS 40 0.0039
692 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 706 0.0039
693 PALPITATIONS 458 0.0039
694 PRODUCT USE IN UNAPPROVED INDICATION 967 0.0039
695 FUNGAL INFECTION 130 0.0039
696 HEPATIC FAILURE 117 0.0039
697 OVERDOSE 835 0.0039
698 RENAL PAIN 41 0.0039
699 PRODUCT DISPENSING ERROR 84 0.0039
700 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 66 0.0038
701 EYE SWELLING 143 0.0038
702 EYE PRURITUS 129 0.0038
703 ELECTROCARDIOGRAM QT PROLONGED 138 0.0038
704 CEREBRAL HAEMORRHAGE 137 0.0038
705 GASTRIC HAEMORRHAGE 44 0.0038
706 CARDIAC FAILURE CONGESTIVE 307 0.0038
707 FULL BLOOD COUNT DECREASED 77 0.0038
708 HEREDITARY ANGIOEDEMA 41 0.0038
709 PHOTOSENSITIVITY REACTION 63 0.0038
710 PANCYTOPENIA 213 0.0038
711 GINGIVAL BLEEDING 52 0.0038
712 CEREBROVASCULAR ACCIDENT 644 0.0038
713 PULMONARY EMBOLISM 360 0.0038
714 INCONTINENCE 40 0.0038
715 EPISTAXIS 283 0.0038
716 DYSPHONIA 221 0.0038
717 RECTAL HAEMORRHAGE 162 0.0038
718 SOMNOLENCE 759 0.0038
719 DRY EYE 188 0.0038
720 HEPATOMEGALY 37 0.0038
721 ARRHYTHMIA 178 0.0038
722 INFLUENZA LIKE ILLNESS 309 0.0038
723 HEADACHE 2349 0.0037
724 HAEMORRHOIDS 73 0.0037
725 ROTATOR CUFF SYNDROME 48 0.0037
726 RENAL INJURY 111 0.0037
727 ERUCTATION 72 0.0037
728 POOR QUALITY SLEEP 80 0.0037
729 EYE DISORDER 122 0.0037
730 DISORIENTATION 147 0.0037
731 ECZEMA 194 0.0037
732 TREATMENT FAILURE 305 0.0037
733 END STAGE RENAL DISEASE 67 0.0037
734 HEART RATE IRREGULAR 83 0.0037
735 URTICARIA 612 0.0036
736 TOOTHACHE 66 0.0036
737 DRY SKIN 486 0.0036
738 EYE INFECTION 41 0.0036
739 RESTLESSNESS 132 0.0036
740 VIRAL INFECTION 120 0.0036
741 PANIC ATTACK 131 0.0036
742 CHOLECYSTECTOMY 41 0.0036
743 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
744 BLINDNESS 146 0.0036
745 NEUTROPHIL COUNT DECREASED 146 0.0036
746 HYPOACUSIS 154 0.0036
747 KNEE ARTHROPLASTY 75 0.0036
748 GASTRIC DISORDER 122 0.0036
749 VISION BLURRED 488 0.0036
750 TENDONITIS 55 0.0035
751 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
752 INJECTION SITE NODULE 39 0.0035
753 CHILLS 415 0.0035
754 DYSPHAGIA 336 0.0035
755 CARDIAC DISORDER 331 0.0035
756 HERPES ZOSTER 203 0.0035
757 SKIN DISORDER 117 0.0035
758 PERICARDIAL EFFUSION 81 0.0035
759 SKIN LESION 96 0.0035
760 PERIPHERAL COLDNESS 48 0.0035
761 THYROID CANCER 42 0.0035
762 COLON CANCER 52 0.0035
763 OCULAR HYPERAEMIA 165 0.0035
764 METASTASES TO BONE 57 0.0035
765 INSOMNIA 923 0.0035
766 SURGERY 203 0.0035
767 PAIN IN JAW 98 0.0035
768 ANGIOEDEMA 153 0.0035
769 JAUNDICE 93 0.0035
770 GASTROINTESTINAL PAIN 38 0.0035
771 BURNING SENSATION 242 0.0034
772 UPPER GASTROINTESTINAL HAEMORRHAGE 58 0.0034
773 SKIN DISCOLOURATION 158 0.0034
774 LOWER LIMB FRACTURE 66 0.0034
775 PROCEDURAL PAIN 95 0.0034
776 OSTEOMYELITIS 62 0.0034
777 SPINAL PAIN 40 0.0034
778 RESPIRATORY ARREST 94 0.0034
779 PNEUMOTHORAX 54 0.0034
780 THERAPY INTERRUPTED 243 0.0034
781 DEMENTIA 95 0.0034
782 ULCER 54 0.0034
783 PRODUCT SUBSTITUTION ISSUE 195 0.0034
784 PYREXIA 1171 0.0034
785 PULMONARY ARTERIAL HYPERTENSION 49 0.0034
786 ILEUS 42 0.0034
787 PAIN 2075 0.0034
788 INCORRECT PRODUCT ADMINISTRATION DURATION 73 0.0034
789 COAGULOPATHY 56 0.0034
790 BLOOD TEST ABNORMAL 47 0.0033
791 DISABILITY 66 0.0033
792 HYPERSENSITIVITY 619 0.0033
793 PLATELET COUNT DECREASED 355 0.0033
794 SWOLLEN TONGUE 104 0.0033
795 DYSGEUSIA 247 0.0033
796 RASH PRURITIC 180 0.0033
797 BLOOD COUNT ABNORMAL 50 0.0033
798 BACTERAEMIA 39 0.0033
799 ANXIETY 931 0.0033
800 COLITIS 124 0.0033
801 THERAPY PARTIAL RESPONDER 51 0.0033
802 THERAPEUTIC RESPONSE DECREASED 198 0.0033
803 AMNESIA 212 0.0033
804 PLEURAL EFFUSION 198 0.0033
805 DERMATITIS ATOPIC 170 0.0032
806 PLATELET COUNT INCREASED 42 0.0032
807 IMMUNODEFICIENCY 48 0.0032
808 SUBDURAL HAEMATOMA 46 0.0032
809 JOINT STIFFNESS 84 0.0032
810 HEPATOTOXICITY 71 0.0032
811 MENTAL IMPAIRMENT 77 0.0032
812 ORAL PAIN 71 0.0032
813 MYOCARDIAL INFARCTION 553 0.0032
814 UNDERDOSE 230 0.0031
815 INFECTION 455 0.0031
816 GALLBLADDER DISORDER 56 0.0031
817 DISTURBANCE IN ATTENTION 169 0.0031
818 ASCITES 92 0.0031
819 TREMOR 519 0.0031
820 COGNITIVE DISORDER 146 0.0031
821 PALLOR 85 0.0031
822 RASH 1361 0.0031
823 THYROID DISORDER 48 0.0031
824 PRODUCT USE ISSUE 582 0.0031
825 INTENTIONAL PRODUCT MISUSE 271 0.0031
826 EYE IRRITATION 178 0.0031
827 ABDOMINAL PAIN LOWER 78 0.0031
828 VISUAL IMPAIRMENT 382 0.0031
829 WHITE BLOOD CELL COUNT DECREASED 334 0.0031
830 THERAPEUTIC RESPONSE SHORTENED 102 0.0031
831 ORAL HERPES 60 0.0031
832 ALOPECIA 603 0.0031
833 HIP ARTHROPLASTY 47 0.0031
834 ROAD TRAFFIC ACCIDENT 128 0.0031
835 PROSTATIC SPECIFIC ANTIGEN INCREASED 42 0.0030
836 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78 0.0030
837 RASH ERYTHEMATOUS 144 0.0030
838 MENTAL DISORDER 130 0.0030
839 INCREASED APPETITE 57 0.0030
840 INTENTIONAL SELF-INJURY 60 0.0030
841 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
842 PSORIASIS 386 0.0030
843 ORAL DISCOMFORT 41 0.0029
844 PRODUCT AVAILABILITY ISSUE 67 0.0029
845 THROMBOCYTOPENIA 329 0.0029
846 LIVER FUNCTION TEST ABNORMAL 85 0.0029
847 INJECTION SITE REACTION 201 0.0029
848 NERVOUSNESS 151 0.0029
849 VISUAL ACUITY REDUCED 96 0.0029
850 ADVERSE EVENT 265 0.0029
851 IMPAIRED QUALITY OF LIFE 41 0.0028
852 NEEDLE ISSUE 83 0.0028
853 PANCREATIC CARCINOMA 82 0.0028
854 CHROMATURIA 64 0.0028
855 ANOSMIA 41 0.0028
856 LYMPHOPENIA 40 0.0028
857 HALLUCINATION 213 0.0028
858 PSYCHOTIC DISORDER 83 0.0028
859 ERYTHEMA 577 0.0028
860 RASH MACULAR 98 0.0028
861 CYANOSIS 44 0.0028
862 LYMPHADENOPATHY 99 0.0028
863 FEELING ABNORMAL 670 0.0028
864 HAEMATOCHEZIA 154 0.0028
865 LABORATORY TEST ABNORMAL 82 0.0028
866 MUSCLE TIGHTNESS 45 0.0028
867 GASTROINTESTINAL HAEMORRHAGE 232 0.0028
868 HEAD DISCOMFORT 49 0.0028
869 NEUTROPENIA 374 0.0027
870 MUCOSAL INFLAMMATION 72 0.0027
871 EXPOSURE VIA SKIN CONTACT 71 0.0027
872 PARAESTHESIA ORAL 39 0.0027
873 AGITATION 198 0.0027
874 SCAR 46 0.0027
875 PARALYSIS 38 0.0027
876 THROAT TIGHTNESS 71 0.0026
877 DERMATITIS 55 0.0026
878 INJECTION SITE MASS 97 0.0026
879 HEPATOCELLULAR INJURY 37 0.0026
880 TOOTH DISORDER 58 0.0026
881 DYSKINESIA 106 0.0026
882 BLOOD BILIRUBIN INCREASED 70 0.0026
883 HIP FRACTURE 83 0.0026
884 ANAPHYLACTIC SHOCK 66 0.0026
885 INTESTINAL OBSTRUCTION 96 0.0025
886 FEBRILE NEUTROPENIA 167 0.0025
887 ECONOMIC PROBLEM 38 0.0025
888 OFF LABEL USE 2187 0.0025
889 PRURITUS GENERALISED 54 0.0025
890 BONE PAIN 146 0.0025
891 ABSCESS 39 0.0024
892 DEEP VEIN THROMBOSIS 158 0.0024
893 NERVOUS SYSTEM DISORDER 75 0.0024
894 PREGNANCY 48 0.0024
895 POST PROCEDURAL COMPLICATION 46 0.0024
896 PNEUMONITIS 65 0.0024
897 MOOD ALTERED 65 0.0024
898 SWELLING FACE 155 0.0024
899 TINNITUS 109 0.0024
900 FACE OEDEMA 40 0.0024
901 MANIA 39 0.0024
902 SENSORY DISTURBANCE 38 0.0024
903 PRODUCT PRESCRIBING ISSUE 51 0.0023
904 MUSCULOSKELETAL DISORDER 44 0.0023
905 PRODUCT QUALITY ISSUE 312 0.0023
906 EXTRAPYRAMIDAL DISORDER 57 0.0023
907 HAEMORRHAGE 237 0.0023
908 NEOPLASM MALIGNANT 151 0.0023
909 PARANOIA 39 0.0023
910 SEIZURE 260 0.0022
911 PRODUCT PHYSICAL ISSUE 45 0.0022
912 DEVICE USE ISSUE 39 0.0022
913 HOSPITALISATION 341 0.0022
914 STAPHYLOCOCCAL INFECTION 73 0.0022
915 CONJUNCTIVITIS 41 0.0022
916 ANGER 74 0.0022
917 SKIN CANCER 47 0.0022
918 INJECTION SITE PAIN 667 0.0022
919 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
920 DEAFNESS 56 0.0021
921 FEMUR FRACTURE 66 0.0021
922 DRUG INEFFECTIVE 2805 0.0021
923 LEUKOPENIA 106 0.0021
924 DRUG ABUSE 176 0.0021
925 INCORRECT DOSE ADMINISTERED 472 0.0021
926 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 48 0.0021
927 UPPER LIMB FRACTURE 41 0.0021
928 NIGHTMARE 69 0.0020
929 ABORTION SPONTANEOUS 78 0.0019
930 ABNORMAL BEHAVIOUR 77 0.0019
931 FEELING JITTERY 37 0.0019
932 PAIN OF SKIN 52 0.0019
933 MALIGNANT NEOPLASM PROGRESSION 196 0.0019
934 SUICIDAL IDEATION 175 0.0019
935 SPINAL FRACTURE 38 0.0019
936 FEAR 51 0.0019
937 MULTIPLE SCLEROSIS 90 0.0019
938 CRYING 68 0.0019
939 BLADDER CANCER 110 0.0019
940 BONE MARROW FAILURE 37 0.0018
941 UNEVALUABLE EVENT 137 0.0018
942 INJECTION SITE BRUISING 144 0.0018
943 INJECTION SITE SWELLING 136 0.0018
944 DISEASE PROGRESSION 210 0.0018
945 INJECTION SITE PRURITUS 117 0.0017
946 RASH GENERALISED 45 0.0017
947 IRRITABILITY 104 0.0017
948 ANHEDONIA 45 0.0017
949 ABNORMAL DREAMS 47 0.0017
950 RASH PAPULAR 38 0.0017
951 LIP SWELLING 56 0.0017
952 LUNG NEOPLASM MALIGNANT 69 0.0017
953 AGGRESSION 82 0.0016
954 MULTIPLE SCLEROSIS RELAPSE 112 0.0016
955 EXPIRED PRODUCT ADMINISTERED 54 0.0016
956 SKIN BURNING SENSATION 116 0.0016
957 NEOPLASM PROGRESSION 56 0.0016
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 315 0.0016
959 INJECTION SITE HAEMORRHAGE 124 0.0016
960 INJECTION SITE ERYTHEMA 191 0.0015
961 DISEASE RECURRENCE 72 0.0015
962 EXTRA DOSE ADMINISTERED 61 0.0015
963 INJECTION SITE RASH 45 0.0015
964 DRUG ADMINISTRATION ERROR 45 0.0015
965 DEATH 1249 0.0014
966 COLITIS ULCERATIVE 64 0.0014
967 THERAPY CESSATION 73 0.0014
968 MOOD SWINGS 45 0.0014
969 EMOTIONAL DISORDER 42 0.0014
970 PROSTATE CANCER 100 0.0012
971 ACCIDENTAL EXPOSURE TO PRODUCT 127 0.0012
972 DEVICE ISSUE 110 0.0012
973 DEVICE DISLOCATION 53 0.0012
974 DEVICE MALFUNCTION 83 0.0012
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 55 0.0012
976 DEVICE LEAKAGE 51 0.0012
977 PRODUCT STORAGE ERROR 102 0.0012
978 PLASMA CELL MYELOMA 44 0.0011
979 EMOTIONAL DISTRESS 136 0.0011
980 WITHDRAWAL SYNDROME 47 0.0011
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
982 MYELOSUPPRESSION 40 0.0011
983 BREAST CANCER 101 0.0011
984 NO ADVERSE EVENT 196 0.0011
985 DRUG DOSE OMISSION 169 0.0010
986 PRODUCT DOSE OMISSION 64 0.0010
987 VAGINAL HAEMORRHAGE 42 0.0010
988 CONVULSION 53 0.0009
989 ACNE 68 0.0009
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63 0.0009
991 SKIN IRRITATION 40 0.0009
992 RENAL CANCER 40 0.0008
993 DRUG DEPENDENCE 93 0.0006